Magenta Life

Why is Magenta Lifecare Ltd falling/rising?

As of 01-Sep, Magenta Lifecare Ltd's stock price is at 8.18, showing a significant decline of 19.41% over the past month and 43.59% over the past year, underperforming compared to the Sensex. The stock is trading below key moving averages and has seen a 50% decrease in trading volume, indicating a bearish trend and declining investor interest.

As of 01-Sep, Magenta Lifecare Ltd's stock price is currently at 8.18, with no change from the previous trading session. The stock has experienced a significant decline over various periods, including a 19.41% drop over the past month and a 43.59% decrease over the past year. In comparison to the benchmark Sensex, which has fallen by only 1.47% in the last month and 4.26% over the past year, Magenta Lifecare's performance has been notably worse.<BR><BR>The stock is currently trading 4.16% above its 52-week low of Rs 7.84, indicating it is close to this low point. Additionally, the stock has underperformed in terms of trading volume, with a 50% decrease in delivery volume compared to the 5-day average. This suggests a decline in investor interest and participation. Furthermore, Magenta Lifecare is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, which typically indicates a bearish trend.<BR><BR>Overall, the combination of poor performance relative to the market, decreasing trading volume, and trading below key moving averages contributes to the stock's downward trajectory.

What does Magenta Life do?

Magenta Lifecare Ltd is a manufacturer of foam-based products like mattresses and pillows, operating in the Micro Cap segment of the Furniture and Home Furnishing industry. The company transitioned to a Public Limited status in July 2023, with a market cap of INR 6 Cr and key metrics including a P/E ratio of 40.00 and a debt-equity ratio of 0.33.

Overview: <BR>Magenta Lifecare Ltd is a manufacturer of foam-based products such as mattresses and pillows, operating in the Furniture and Home Furnishing industry within the Micro Cap market segment.<BR><BR>History: <BR>Magenta Lifecare Ltd was originally incorporated as "Magenta Lifecare Private Limited" on August 04, 2015. The company transitioned to a Public Limited status and changed its name to "Magenta Lifecare Limited" on July 05, 2023. Revenue and profit data for the latest quarter are not available.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: N/A <BR>Most recent Net Profit: N/A <BR>Market-cap value: INR 6 Cr (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: 40.00 <BR>Industry P/E: N/A <BR>Dividend Yield: 0.00% <BR>Debt-Equity: 0.33 <BR>Return on Equity: 1.05% <BR>Price-to-Book: 0.42<BR><BR>Contact Details: <BR>Registrar Address: Not available. <BR>Phone: Not available. <BR>Email: Not available. <BR>Website: Not available.

Who are the peers of the Magenta Life?

Magenta Life's peers include Milestone Furn., BirlaNu Ltd, Stanley Lifesty., Hardwyn India, Tirupati Foam, Shashwat Furnis., Golden Carpets, Rexpro Enter., and Safe Enterprises. Most peers exhibit below-average growth and management risk, with Milestone Furn. showing the highest 1-year return at 92.29%.

Peers: The peers of Magenta Life are Milestone Furn., BirlaNu Ltd, Stanley Lifesty., Hardwyn India, Tirupati Foam, Shashwat Furnis., Golden Carpets, Rexpro Enter., and Safe Enterprises.<BR><BR>Quality Snapshot: Below Average management risk is observed at BirlaNu Ltd, Stanley Lifesty., Shashwat Furnis., and Rexpro Enter., while Average management risk is found at Hardwyn India, Tirupati Foam, and Safe Enterprises. Magenta Life also has Below Average management risk. Growth is Below Average for BirlaNu Ltd, Stanley Lifesty., Hardwyn India, Tirupati Foam, Shashwat Furnis., and Magenta Life, while Safe Enterprises shows Excellent growth. Capital Structure ratings are Excellent for Hardwyn India, Good for Rexpro Enter., Average for Stanley Lifesty. and Shashwat Furnis., and Below Average for the rest.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Milestone Furn. at 92.29%, while Stanley Lifesty. has the lowest at -54.84%. Magenta Life's 1-year return is not available for comparison. Additionally, the peers with negative six-month returns include Milestone Furn., Hardwyn India, and Magenta Life.

Which are the latest news on Magenta Life?

How big is Magenta Life?

As of 10th June, Magenta Lifecare Ltd has a market capitalization of 6.00 Cr, classifying it as a Micro Cap company. There is no valid financial data available for the latest quarterly performance, but as of March 2025, Shareholder's Funds are 13.92 Cr and Total Assets are 18.10 Cr.

As of 10th June, <BR><BR>Market Cap: Magenta Lifecare Ltd has a market capitalization of 6.00 Cr, classifying it as a Micro Cap company.<BR><BR>Recent Quarterly Performance: There is no valid financial data available for the latest quarterly performance, including Net Sales and Net Profit for the latest four quarters.<BR><BR>Balance Sheet Snapshot: The latest reporting period is March 2025, with Shareholder's Funds amounting to 13.92 Cr and Total Assets valued at 18.10 Cr.

When is the next results date for Magenta Lifecare Ltd?

The next results date for Magenta Lifecare Ltd is 28 May 2026.

The next results date for Magenta Lifecare Ltd is scheduled for 28 May 2026.

Is Magenta Life overvalued or undervalued?

As of June 2, 2025, Magenta Life's valuation has shifted to risky, indicating it is overvalued with a PE ratio of 10.52 and a year-to-date return of -36.4%, underperforming compared to the Sensex's 5.54%.

As of 2 June 2025, the valuation grade for Magenta Life has moved from does not qualify to risky, indicating a significant shift in its perceived investment quality. The company appears to be overvalued based on its current financial ratios, which include a PE ratio of 10.52, a Price to Book Value of 1.54, and an EV to EBIT of -13.60. These figures suggest that the market may not be accurately reflecting the company's underlying financial health.<BR><BR>In comparison to its peers, Magenta Life's valuation stands out unfavorably. For instance, Metro Brands is categorized as very expensive with a PE ratio of 95.29, while V-Guard Industries Ltd. is rated fair with a PE of 52.15. The stark contrast in valuations highlights that Magenta Life may not be justified at its current price level. Additionally, the company's stock has underperformed relative to the Sensex, with a year-to-date return of -36.4% compared to the Sensex's 5.54%, reinforcing the notion that it is overvalued in the current market context.

What is the technical trend for Magenta Life?

As of May 9, 2025, Magenta Life's technical trend is mildly bearish, influenced by bearish daily moving averages and Bollinger Bands, despite a mildly bullish weekly MACD and a mixed outlook from Dow Theory.

As of 9 May 2025, the technical trend for Magenta Life has changed from does not qualify to mildly bearish. The current technical stance is mildly bearish, driven by several key indicators. The weekly MACD is mildly bullish, but the daily moving averages are bearish, indicating short-term weakness. The weekly Bollinger Bands also reflect a bearish sentiment. Additionally, the Dow Theory shows a mildly bearish stance on the weekly timeframe, while the monthly perspective is mildly bullish. Overall, the mixed signals suggest a cautious outlook, with bearish tendencies prevailing in the short term.

How has been the historical performance of the Magenta Life?

Magenta Life's historical performance shows declining net sales from Rs 9.24 crore in March 2022 to Rs 8.76 crore in March 2024, but profitability metrics improved, with profit after tax rising to Rs 0.74 crore and earnings per share increasing to Rs 1.52. Overall, while sales decreased, operational efficiency has enhanced profitability.

Answer:<BR>The historical performance of Magenta Life shows a mixed trend in financial metrics over the past three years.<BR><BR>Breakdown:<BR>In terms of net sales, Magenta Life reported Rs 8.76 crore in March 2024, a decline from Rs 9.07 crore in March 2023 and Rs 9.24 crore in March 2022. The total operating income mirrored this trend, remaining at Rs 8.76 crore in March 2024, down from Rs 9.07 crore in the previous year. Raw material costs decreased to Rs 5.38 crore in March 2024 from Rs 6.01 crore in March 2023, contributing to a total expenditure of Rs 7.27 crore, which also saw a reduction from Rs 8.20 crore in March 2023. Operating profit, excluding other income, improved to Rs 1.49 crore in March 2024 from Rs 0.87 crore in March 2023, leading to an overall operating profit of Rs 1.77 crore in March 2024. Profit before tax rose significantly to Rs 1.02 crore in March 2024 from Rs 0.32 crore in March 2023, resulting in a profit after tax of Rs 0.74 crore, up from Rs 0.25 crore the previous year. The earnings per share also increased to Rs 1.52 in March 2024 from Rs 0.54 in March 2023. On the balance sheet, total liabilities rose to Rs 13.06 crore in March 2024 from Rs 12.51 crore in March 2023, while total assets increased slightly to Rs 13.06 crore from Rs 12.51 crore. Cash flow from operating activities remained at Rs 0.00 for March 2024, indicating no cash inflow or outflow from operations during the year. Overall, while sales have declined, profitability metrics have shown improvement, reflecting a positive trend in operational efficiency.

Who are the top shareholders of the Magenta Life?

The top shareholder of Magenta Life is Divyesh Vipinchandra Modi, holding 31.42%. Other significant shareholders include 7nr Retail Limited at 6.11% and individual investors with a combined 30.02%.

The top shareholders of Magenta Life include the promoters, with Divyesh Vipinchandra Modi holding the largest stake at 31.42%. There are no pledged promoter holdings, and mutual funds and foreign institutional investors do not hold any shares in the company. The highest public shareholder is 7nr Retail Limited, which owns 6.11%. Additionally, individual investors collectively hold 30.02% of the shares.

Has Magenta Life declared dividend?

No Dividend History Available